报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 5.22% | -75% | 88.45% | 15/52 | 3.55% | 澳洋健康 | 34.16% | 行业排名> |
2024-06-30 | 2.77% | -80.68% | 37.81% | 16/52 | 2.24% | 澳洋健康 | 30.56% | 行业排名> |
2024-03-31 | 2.01% | 2% | -86.79% | 11/52 | 1.22% | 澳洋健康 | 28.14% | 行业排名> |
2023-12-31 | 15.22% | -50.07% | -27.11% | 5/52 | 3.83% | 澳洋健康 | 39.54% | 行业排名> |
2023-09-30 | 20.88% | 2% | 45.61% | 2/52 | 6.78% | 澳洋健康 | 61.84% | 行业排名> |
2023-06-30 | 14.34% | 14.54% | -52.95% | 2/52 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
2022-12-31 | 30.48% | -19.34% | 143.45% | 4/52 | -0.52% | 澳洋健康 | 58.19% | 行业排名> |
2022-06-30 | 12.52% | -40.69% | -66.87% | 8/52 | 5.46% | *ST宜康 | 75.53% | 行业排名> |
2021-12-31 | 37.79% | -27.4% | 79.01% | 2/52 | -6.4% | 博腾股份 | 39.77% | 行业排名> |
2021-06-30 | 21.11% | 2% | -59.44% | 3/52 | 2.32% | 睿智医药 | 41.16% | 行业排名> |
2020-12-31 | 52.05% | -26.53% | -26.53% | 1/52 | 10.94% | 澳洋健康 | 51.68% | 行业排名> |
2019-12-31 | 70.85% | -33.61% | -33.61% | 2/52 | 64.11% | 澳洋健康 | 40.93% | 行业排名> |
2018-12-31 | 106.72% | 2% | 2% | 1/52 | -0.5% | 金域医学 | 43.58% | 行业排名> |